Assenagon Asset Management S.A. lowered its position in Maximus, Inc. (NYSE:MMS – Free Report) by 84.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 140,115 shares of the health services provider’s stock after selling 738,779 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.23% of Maximus worth $10,460,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Eastern Bank purchased a new stake in shares of Maximus during the 4th quarter worth $29,000. Reinhart Partners LLC. boosted its position in shares of Maximus by 43.5% during the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after acquiring an additional 167,019 shares in the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of Maximus by 45.2% in the 4th quarter. Harbor Capital Advisors Inc. now owns 47,956 shares of the health services provider’s stock valued at $3,580,000 after acquiring an additional 14,937 shares during the last quarter. Diversified Trust Co raised its position in shares of Maximus by 24.7% during the 4th quarter. Diversified Trust Co now owns 10,388 shares of the health services provider’s stock worth $775,000 after acquiring an additional 2,056 shares in the last quarter. Finally, Nordea Investment Management AB purchased a new stake in Maximus during the fourth quarter worth approximately $4,618,000. Institutional investors and hedge funds own 97.21% of the company’s stock.
Maximus Stock Down 0.4 %
Shares of NYSE MMS opened at $78.49 on Friday. The business has a 50-day moving average price of $75.64 and a 200 day moving average price of $84.61. The stock has a market cap of $4.73 billion, a PE ratio of 15.70 and a beta of 0.73. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus, Inc. has a 52-week low of $69.72 and a 52-week high of $93.97.
Maximus Dividend Announcement
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, December 27th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research note on Thursday, January 2nd.
Insider Buying and Selling
In related news, CEO Bruce Caswell acquired 3,500 shares of Maximus stock in a transaction on Tuesday, December 17th. The stock was purchased at an average cost of $70.64 per share, with a total value of $247,240.00. Following the purchase, the chief executive officer now directly owns 275,929 shares in the company, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired a total of 7,063 shares of company stock worth $502,017 in the last 90 days. Company insiders own 1.40% of the company’s stock.
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
- Five stocks we like better than Maximus
- What is a Secondary Public Offering? What Investors Need to Know
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What is Forex and How Does it Work?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How Technical Indicators Can Help You Find Oversold Stocks
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.